Cargando…
Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass
Background and Objectives: Peripheral artery disease is one of the most common vascular pathologies. There is an ongoing debate among specialists on whether open or endovascular revascularization is preferred in cases of complex superficial femoral artery (SFA) lesions. The purpose of this study was...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059675/ https://www.ncbi.nlm.nih.gov/pubmed/36984464 http://dx.doi.org/10.3390/medicina59030462 |
_version_ | 1785016930570076160 |
---|---|
author | Rumba, Roberts Krievins, Dainis Savlovskis, Janis Ezite, Natalija Lacis, Aigars Petrosina, Eva Mouttet, Ludovic Gardovskis, Janis Zarins, Christopher K. |
author_facet | Rumba, Roberts Krievins, Dainis Savlovskis, Janis Ezite, Natalija Lacis, Aigars Petrosina, Eva Mouttet, Ludovic Gardovskis, Janis Zarins, Christopher K. |
author_sort | Rumba, Roberts |
collection | PubMed |
description | Background and Objectives: Peripheral artery disease is one of the most common vascular pathologies. There is an ongoing debate among specialists on whether open or endovascular revascularization is preferred in cases of complex superficial femoral artery (SFA) lesions. The purpose of this study was to assess patency results of a relatively new transvenous endovascular bypass device. This could add to existing evidence and aid in comparison between open and endovascular bypass. Materials and Methods: Patients with complex TASC-C and D SFA lesions who had indications for revascularization were identified. Prospective analysis of stent graft patency from 54 transvenous femoropopliteal bypass procedures was performed. Patency was assessed by Duplex ultrasound every six months. Kaplan–Meier analysis was performed to assess primary, primary-assisted, and secondary patency of transvenous bypass. Results: Following endovascular transvenous femoropopliteal bypass, 3-year graft primary, primary-assisted, and secondary patency was 43.8%, 66.3%, and 73.9%, respectively. Conclusions: Transvenous endovascular femoropopliteal bypass is a viable option for selected patients who lack adequate saphenous vein or have comorbidities that increase the risk of open femoropopliteal bypass. Strict post-operative follow-up is necessary to improve patency rates. |
format | Online Article Text |
id | pubmed-10059675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100596752023-03-30 Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass Rumba, Roberts Krievins, Dainis Savlovskis, Janis Ezite, Natalija Lacis, Aigars Petrosina, Eva Mouttet, Ludovic Gardovskis, Janis Zarins, Christopher K. Medicina (Kaunas) Article Background and Objectives: Peripheral artery disease is one of the most common vascular pathologies. There is an ongoing debate among specialists on whether open or endovascular revascularization is preferred in cases of complex superficial femoral artery (SFA) lesions. The purpose of this study was to assess patency results of a relatively new transvenous endovascular bypass device. This could add to existing evidence and aid in comparison between open and endovascular bypass. Materials and Methods: Patients with complex TASC-C and D SFA lesions who had indications for revascularization were identified. Prospective analysis of stent graft patency from 54 transvenous femoropopliteal bypass procedures was performed. Patency was assessed by Duplex ultrasound every six months. Kaplan–Meier analysis was performed to assess primary, primary-assisted, and secondary patency of transvenous bypass. Results: Following endovascular transvenous femoropopliteal bypass, 3-year graft primary, primary-assisted, and secondary patency was 43.8%, 66.3%, and 73.9%, respectively. Conclusions: Transvenous endovascular femoropopliteal bypass is a viable option for selected patients who lack adequate saphenous vein or have comorbidities that increase the risk of open femoropopliteal bypass. Strict post-operative follow-up is necessary to improve patency rates. MDPI 2023-02-25 /pmc/articles/PMC10059675/ /pubmed/36984464 http://dx.doi.org/10.3390/medicina59030462 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rumba, Roberts Krievins, Dainis Savlovskis, Janis Ezite, Natalija Lacis, Aigars Petrosina, Eva Mouttet, Ludovic Gardovskis, Janis Zarins, Christopher K. Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass |
title | Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass |
title_full | Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass |
title_fullStr | Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass |
title_full_unstemmed | Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass |
title_short | Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass |
title_sort | three-year patency results following endovascular transvenous femoropopliteal bypass |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059675/ https://www.ncbi.nlm.nih.gov/pubmed/36984464 http://dx.doi.org/10.3390/medicina59030462 |
work_keys_str_mv | AT rumbaroberts threeyearpatencyresultsfollowingendovasculartransvenousfemoropoplitealbypass AT krievinsdainis threeyearpatencyresultsfollowingendovasculartransvenousfemoropoplitealbypass AT savlovskisjanis threeyearpatencyresultsfollowingendovasculartransvenousfemoropoplitealbypass AT ezitenatalija threeyearpatencyresultsfollowingendovasculartransvenousfemoropoplitealbypass AT lacisaigars threeyearpatencyresultsfollowingendovasculartransvenousfemoropoplitealbypass AT petrosinaeva threeyearpatencyresultsfollowingendovasculartransvenousfemoropoplitealbypass AT mouttetludovic threeyearpatencyresultsfollowingendovasculartransvenousfemoropoplitealbypass AT gardovskisjanis threeyearpatencyresultsfollowingendovasculartransvenousfemoropoplitealbypass AT zarinschristopherk threeyearpatencyresultsfollowingendovasculartransvenousfemoropoplitealbypass |